- Home
- Case Studies
- Life Sciences Leader Achieves 22% Travel Spend Reduction
Life Sciences Leader Achieves 22% Travel Spend Reduction
A leading pharmaceutical company partnered with Atlas to transform their fragmented travel program into a centralized, data-driven operation — saving $4.2 million annually while improving traveler satisfaction.
The Challenge
The Challenge
This global life sciences company had a decentralized travel program with multiple agencies across regions, inconsistent policies, and limited visibility into total travel spend. With thousands of clinical trial site visits, patient travel arrangements, and conference trips annually, the lack of centralization was costing the organization millions in missed savings opportunities and creating compliance gaps in their duty of care obligations.
The Solution
The Solution
Atlas implemented a phased consolidation strategy, migrating all regions onto a single platform with unified policy enforcement and real-time reporting. Our life sciences specialist team designed custom booking workflows for clinical trial travel that maintained compliance with FDA and EMA regulations while streamlining the booking experience. We also deployed our AI-powered fare optimization engine, which analyzes historical booking patterns and market conditions to recommend optimal booking windows for the company's most-traveled routes.
The Results
Related Services
Ready to see results like these?
Talk to our team about optimizing your travel program.